Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.37 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MME | P08473 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | LTA4H | P09960 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6668476 | 0.89 | TDP1 (0.42) | TDP1SMN1; SMN2SLC22A6GABRR1LMNA | |
| SCHEMBL6668483 | 0.86 | TSHR (0.36) | TDP1SMN1; SMN2KMT2AMMELTA4H | |
| SCHEMBL6670670 | 0.82 | TDP1 (0.50) | TDP1SMN1; SMN2SLC22A6LMNAKMT2A | |
| SCHEMBL9794637 | 0.80 | TDP1 (0.50) | TDP1SMN1; SMN2SLC22A6KMT2AMAPT | |
| SCHEMBL13595128 | 0.80 | TDP1 (0.50) | TDP1SMN1; SMN2SLC22A6KMT2AMAPT | |
| SCHEMBL8472485 | 0.79 | TDP1 (0.52) | TDP1SMN1; SMN2SLC22A6KMT2AMME | |
| SCHEMBL6670982 | 0.79 | TDP1 (0.46) | TDP1SMN1; SMN2SLC22A6LMNA | |
| SCHEMBL6655329 | 0.78 | MME (0.44) | LMNAKMT2AMMELTA4H | |
| SCHEMBL6655326 | 0.78 | MME (0.44) | LMNAKMT2AMMELTA4H | |
| Isocitrate SCHEMBL1289944 | 0.77 | TDP1 (0.68) | TDP1SMN1; SMN2SLC22A6GABRR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4673552-A1 | METHODS FOR PRODUCING L-PIPECOLIC ACID | Universität des Saarlandes (DE) | 2026-01-07 | — | — | EP | disclosed |
| US-12285034-B2 | Human and non-human animal use of microbial anaplerotic oil | HELIAE DEVELOPMENT, LLC (US) | 2025-04-29 | — | — | US | disclosed |
| WO-2024180222-A1 | METHODS FOR PRODUCING L-PIPECOLIC ACID | UNIVERSITAET DES SAARLANDES (DE) | 2024-09-06 | — | — | WO | disclosed |
| US-20230397642-A1 | HUMAN AND NON-HUMAN ANIMAL USE OF MICROBIAL ANAPLEROTIC OIL | HELIAE DEVELOPMENT, LLC | 2023-12-14 | — | — | US | disclosed |
| US-11758934-B2 | Human and non-human animal use of microbial anaplerotic oil | HELIAE DEVELOPMENT, LLC (US) | 2023-09-19 | — | — | US | disclosed |
| US-20220400723-A1 | HUMAN AND NON-HUMAN ANIMAL USE OF MICROBIAL ANAPLEROTIC OIL | HELIAE DEVELOPMENT, LLC | 2022-12-22 | — | — | US | disclosed |
| US-20220396814-A1 | Anaplerotic Oil Production In Microbials | HELIAE DEVELOPMENT, LLC | 2022-12-15 | — | — | US | disclosed |
| US-11457655-B2 | Human and non-human animal use of microbial anaplerotic oil | HELIAE DEVELOPMENT, LLC (US) | 2022-10-04 | — | — | US | disclosed |
| US-11447803-B2 | Anaplerotic oil production in microbials | HELIAE DEVELOPMENT, LLC (US) | 2022-09-20 | — | — | US | disclosed |
| US-11434511-B2 | Anaplerotic oil production in microbials | HELIAE DEVELOPMENT, LLC (US) | 2022-09-06 | — | — | US | disclosed |
| WO-2008024858-A2 | METHODS AND COMPOUNDS REGULATING THE ERYTHROID RESPONSE TO IRON DEFICIENCY | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2008-02-28 | — | — | WO | disclosed |
| EP-1334180-A4 | ISOCITRATE DEHYDROGENASE, GENE THEREOF, AND USE OF THE SAME IN THE TREATMENT OF OBESITY, HYPERLIPIDEMIA, AND FATTY LIVER IN LIPID BIOSYNTHESIS | TG BIOTECH INC (KR) | 2005-04-06 | — | — | EP | disclosed |
| US-20040214270-A1 | Isocitrate dehydrogenase, gene thereof, and use of the same in the treatment of obesity, hyperlipidemia, and fattly liver in lipid biosynthesis | TG BIOTECH, INC. (KR) | 2004-10-28 | — | — | US | disclosed |
| EP-0831767-B1 | ALPHA HYDROXYACID ESTERS FOR SKIN AGING | YU RUEY J (US) | 2004-09-22 | — | — | EP | disclosed |
| EP-1334180-A1 | ISOCITRATE DEHYDROGENASE, GENE THEREOF, AND USE OF THE SAME IN THE TREATMENT OF OBESITY, HYPERLIPIDEMIA, AND FATTY LIVER IN LIPID BIOSYNTHESIS | TG Biotech, Inc. (KR) | 2003-08-13 | — | — | EP | disclosed |
| WO-2002033063-A1 | ISOCITRATE DEHYDROGENASE, GENE THEREOF, AND USE OF THE SAME IN THE TREATMENT OF OBESITY, HYPERLIPIDEMIA, AND FATTY LIVER IN LIPID BIOSYNTHESIS | TG BIOTECH, INC. (KR) | 2002-04-25 | — | — | WO | disclosed |
| EP-0831767-A4 | ALPHA HYDROXYACID ESTERS FOR SKIN AGING | YU RUEY J (US) | 2000-05-17 | — | — | EP | disclosed |
| EP-0831767-A1 | ALPHA HYDROXYACID ESTERS FOR SKIN AGING | Yu, Ruey J., Dr. (US) | 1998-04-01 | — | — | EP | disclosed |
| US-5686489-A | TOPICALLY APPLIED TO INDUCE GLYCOSAMINOGLYCAN, PROTEOGLYCAN, COLLAGEN AND ELASTIN BIOSYNTHESIS; WRINKLE RESISTANCE | TRISTRATA TECHNOLOGY, INC. (US) | 1997-11-11 | — | — | US | disclosed |
| WO-1996040047-A1 | ALPHA HYDROXYACID ESTERS FOR SKIN AGING | YU RUEY J (US) | 1996-12-19 | — | — | WO | disclosed |